scispace - formally typeset
Book ChapterDOI

Unified Parkinson's Disease Rating Scale

Victor R. Preedy, +1 more
- pp 4343-4343
About
The article was published on 2010-01-01. It has received 691 citations till now. The article focuses on the topics: Unified Parkinson's disease rating scale.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.

Christopher G. Goetz, +87 more
- 15 Nov 2008 - 
TL;DR: The combined clinimetric results of this study support the validity of the MDS‐UPDRS for rating PD.
Journal ArticleDOI

Colonic inflammation in Parkinson's disease.

TL;DR: Findings provide evidence that enteric inflammation occurs in Parkinson's disease and further reinforce the role of peripheral inflammation in the initiation and/or the progression of the disease.
Journal ArticleDOI

The Clinically Important Difference on the Unified Parkinson's Disease Rating Scale

TL;DR: In this paper, a cross-sectional analysis of the CIDs for UPDRS total and motor scores was performed on patients with Parkinson disease (PD) using distribution-and anchor-based approaches based on the following external standards: disability (10% on the Schwab and England Activities of Daily Living Scale), disease stage (1 stage on the Hoehn and Yahr Scale), and quality of life (1 SD on the 12-Item Short Form Health Survey).
References
More filters
Journal ArticleDOI

Lighten Up: Specific Postural Instructions Affect Axial Rigidity and Step Initiation in Patients With Parkinson’s Disease

TL;DR: Mindful movement approaches such as AT may benefit balance and mobility in subjects with PD by acutely facilitating increased upright postural alignment while decreasing rigidity.
Journal ArticleDOI

Risks and benefits of unapproved disease-modifying treatments for neurodegenerative disease

TL;DR: The findings suggest that patients with neurodegenerative diseases are not, on the whole, harmed by assignment to placebo when participating in trials.
Journal ArticleDOI

An exploratory study of the efficacy and safety of yokukansan for neuropsychiatric symptoms in patients with Parkinson’s disease

TL;DR: YKS improved neuropsychiatric symptoms associated with PD, including hallucinations, anxiety and apathy without severe adverse events and worsening of Parkinsonism.
Journal ArticleDOI

Health-Related Quality of Life Subdomains in Patients with Parkinson’s Disease: The Role of Gender

TL;DR: Analyses suggest the consideration of a reevaluation of the PDQ-39 and clarify general and domain-specific relationships between clinical, (neuro)psychological, and sociodemographic variables, gender in particular, and HrQoL.